Navigation Links
Analysis: Bowel Diseases Triples Infertility Risks In Women

In the Journal Gut, a research published says major surgery of all inflammatory bowel diseases (such as ulcerative colitis), triples the infertility risks// in women, which was concluded from analysis of many research archives and 8 published studies.

Infertility was defined as a failure to conceive after 12 months of trying. Ulcerative colitis is a condition in which sores and inflammation develop along the lining of the large intestine, producing severe diarrhoea and rectal bleeding. It affects around 1 to 2% of the population. Surgical removal of the colon is sometimes needed to alleviate persistent and painful symptoms.

Ileal pouch anal anastomosis is a standard procedure in which the lower section of the large intestine is removed and a surgical pouch artificially created from the small intestine. This is then joined to a short remaining cuff of the rectum to ensure as normal bowel function as possible.

The evidence from the published studies showed that the risk of infertility after drug treatment was around 1 in 7 or 15%.

But this risk tripled to 48% after ileal pouch anal anastomosis. All patients seemed to be at risk of infertility, so there were no obvious factors among the patients or the procedure itself to account for the increased risk.

Based on previous X-ray studies of the fallopian tubes, which transport ripened eggs from the ovary to the womb, the authors suggest that such extensive surgery may scar or block these tubes.

Source: Newswise
'"/>




Page: 1

Related medicine news :

1. Bowel diseases linked to bug in milk
2. Hope For Patients With Inflammatory Bowel Disease
3. Cannabinoids - Antidepressant And Inflammatory Bowel Disease Treatment
4. Eating Red and Processed Meat may cause Bowel cancer
5. Just Had Bowel Surgery? Chew Gum For A Speedy Recovery
6. Delay In Life-Saving Bowel Cancer Screening Programme In UK
7. National Bowel Cancer Screening Programme Lauded
8. Bowel Cancer Drug Campaigner Dies After Surgery
9. New compounds Help Sustain relief For Patients With Symptoms of Bowel Disorders
10. Parasitic Worms Could Be Used To Treat Bowel Disease
11. Inflammatory Bowel Diseases Cured By Parasitic Worms
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/17/2017)... ... February 17, 2017 , ... ... educational assistance management solution to the exhibit floor for the 2017 HIMSS ... , From Feb. 19–23, 2017, more than 40,000 healthcare industry professionals are ...
(Date:2/17/2017)... ... February 17, 2017 , ... Empowering each person's mental ... for each and every seminar, session and class she offers. At the ... tools which help energize creativity, focus mental functions, enhance athletic focus and skill ...
(Date:2/17/2017)... ... February 17, 2017 , ... Qualis Health, one of ... the 8th Annual DecisionHealth Platinum Awards in recognition of its innovative healthcare management ... recognized across multiple award categories, highlighting four of the organization’s current programs:, ...
(Date:2/17/2017)... ... February 17, 2017 , ... Program ... , Trinity Health and the U.S. Soccer Foundation announced today that they have ... communities. Soccer for Success, the Foundation’s soccer mentoring program, teaches kids the fundamentals ...
(Date:2/17/2017)... ... 2017 , ... Pharmica Consulting attended CHI's 8th Annual SCOPE ... trial planning and management. Pharmica discussed the importance of effective project management, data ... by Pharmica’s booth were able to demo its cloud-based Resource Management Tool, ...
Breaking Medicine News(10 mins):
(Date:2/19/2017)... 19, 2017  nThrive™, an independent Patient-to-Payment? solutions ... thought leadership at the 2017 HIMSS Conference. The ... award from KLAS. nThrive will host ... how market trends shape the holistic, integrated revenue ... comprehensive Patient Access solution. The panel will reveal ...
(Date:2/18/2017)... HILL, N.C. , Feb. 17, 2017  Pharmaceutical companies ... insights about products either in development or already on the ... have forced the pharma industry to alter how it manages ... boards, consulting leader Best Practices, LLC conducted a new study ... ...
(Date:2/17/2017)... Feb. 17, 2017 Theravance Biopharma, Inc. ... the "Company") today announced the presentation of positive ... orally administered pan-Janus kinase (JAK) inhibitor designed to ... Congress of the European Crohn,s and Colitis Organization ... further data from its completed Phase 1 study ...
Breaking Medicine Technology: